Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer.

類似資料

• Intra-patient dose escalation in Ewing’s sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review
  著者:: Lewin, Jeremy, 等
  出版事項: (2013)
• Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors
  著者:: Ziegler, David S., 等
  出版事項: (2006)
• Etoposide compared with the combination of vincristine, doxorubicin, and cyclophosphamide in the treatment of small cell lung cancer.
  著者:: McIllmurray, M B, 等
  出版事項: (1989)
• Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer.
  著者:: Ardizzoni, A., 等
  出版事項: (1994)
• Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovary
  著者:: Wallbillich, John J., 等
  出版事項: (2012)